I'd take the particular claims - "Some of them even had their voices come back" - with a huge dose of salt. But your wider point is valid: positive word of mouth is likely driving a surge in enrollment.
It seems to me that the trial has morphed. Initially it was about safety and side effects, with efficacy necessarily a secondary concern in a phase 2 trial. But the additional enrollments are all at the highest dose (or placebo). That suggests safety is no longer a significant concern. The trial is double-blind, but safety and toxicity would be monitored throughout by a separate committee. This committee must have given the green light for maximum-dose v placebo for all new enrollments. And that suggest the objective of the extension is really about efficacy, to give the best possible chance to record a statistically significant difference between drug and placebo.
This is important. I'd imagine there would be a significant placebo effect in a trial like this; the parents invest so much hope in a trial like this. So congratulations to the company for being agile and flexible enough to extend the trial in such a way that gives it the best chance of demonstrating efficacy.
Doesn't mean the drug works, but they're giving it the best chance to demonstrate if it does or not.
GLTAH
- Forums
- ASX - By Stock
- NEU
- Story about Trof trial
Story about Trof trial, page-4
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$17.09 |
Change
0.000(0.00%) |
Mkt cap ! $2.184B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 582 | $17.95 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.00 | 1600 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 582 | 17.950 |
1 | 550 | 17.500 |
1 | 100 | 17.150 |
1 | 877 | 17.090 |
1 | 100 | 17.050 |
Price($) | Vol. | No. |
---|---|---|
14.000 | 1600 | 1 |
14.990 | 1786 | 1 |
15.000 | 4229 | 4 |
15.250 | 900 | 1 |
15.290 | 1655 | 1 |
Last trade - 16.36pm 07/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
Day chart unavailable